3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Endocrine
1
Conditions
Breast Neoplasms
2
Papillomavirus Infections
1
Osteoporosis
1
Multiple Endocrine Neoplasia Type 1
1
Lung Neoplasms
1
Inflammatory Bowel Diseases
1
Infertility
1
High Grade Cervical Intraepithelial Neoplasia
1
Interventions
Zoledronic Acid
14
Vitamin D
8
Risedronic Acid
8
Letrozole
7
Calcium
7
Calcium Carbonate
5
Absorptiometry, Photon
5
Cholecalciferol
4
Denosumab
3
Alendronate
3
bicalutamide
2
Resistance Training
2
Nutrition Assessment
2
Kyphoplasty
2
Hormone Replacement Therapy
2
Calcium Gluconate
2
Calcium Citrate
2
Aromatase Inhibitors
2
Anastrozole
2
xian ling gu bao
1
parathyroid hormone-related peptide (1-36)
1
X-Rays
1
Toremifene
1
Technetium
1
Raloxifene Hydrochloride
1
Radiotherapy
1
Progestins
1
Lysine Acetyltransferase 5
1
Linseed Oil
1
Ibandronic Acid
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Osteoporosis
×
Biological Products
×
Clear all
NCT01250314
2012-07-03
OSTEHOM
Assistance Publique - Hôpitaux de Paris
Phase NA
Completed
79 enrolled